Vaccine Choice Canada Influenza - Disease & Vaccine Information

Influenza

Influenza symptoms include fever, chills, sore throat, muscle aches, and cough. People tend to use the term “flu” to describe any kind of respiratory or gastrointestinal illness, however, over 70% of respiratory infections are caused by pathogens other than influenza. The influenza vaccine will have no effect with these flu-like conditions. The vast majority of people naturally recover from influenza without any complications and may develop protection from future infection with the same strain or a related strain.

The Vaccine

Influenza viruses are highly unstable with a known propensity for mutating from season to season such that the vaccine must be redesigned each year because the immunity generated from one’s season’s vaccination may not provide any protection for next season’s mutated virus.

The vaccine is made from strains of the flu that are predicted to circulate in the coming year. When the strains included in the vaccine differ markedly from those in circulation, the vaccine’s effectiveness can be zero. The manufacturer states: The vaccine “will not protect against any other strains of flu virus” not contained in the vaccine.

Influenza vaccines administered via injection are inactivated viruses that are made using chicken embryos, insect cells, or dog kidney cells.
Influenza vaccines packaged in multi-dose vials contain thimerosal, a mercury-based neurotoxin.
The live virus vaccine (nasal spray) sheds the virus, meaning the vaccine derived live virus is present in bodily fluids of a recently vaccinated individual.
Most provinces recommend the influenza vaccine in pregnant women and infants starting at 6 months of age, and then annually.

Considerations for the Vaccine Decision

Even though the influenza vaccine has different strains each year, manufacturers are not required to assess the safety and efficacy of the vaccine as a condition of licencing.
Annual vaccination reduces protective immunity against more virulent pandemic strains. [28]
Natural immunity provides cross-protection against other strains. This cross protection is not available to vaccinated individuals.
Health Canada recommends that all pregnant women receive the influenza vaccine during each pregnancy. The U.S. Food and Drug Administration’s (FDA) risk summary for the flu vaccine states: “There are insufficient data on FLULAVAL in pregnant women to inform vaccine-associated risks.” “Data are not available to assess the effects of FLULAVAL on the breastfed infant or on milk production/excretion.”
There is no evidence that vaccinating the elderly improves survivability rates, or that vaccinating health care workers protects patients.

As of March 31, 2023, there have been more than 216,647 reports of vaccine reactions, hospitalizations, injuries and deaths following influenza vaccinations made to the Vaccine Adverse Events Reporting System, including 2,350 related deaths.[29]

A US HHS study acknowledged that less than 1% of vaccine adverse events are reported. [30]
The safety of the influenza vaccine has not been proven against a true placebo.

For more information: https://www.nvic.org/disease-vaccine/influenza

2025 Cleveland Clinic Study - Bombshell Study Reveals 27% Negative Efficacy of 2024-2025 Influenza Vaccine Among Working-Age Adults

A newly released preprint study from the Cleveland Clinic has sparked international attention by reporting that the influenza vaccine for the 2024-2025 season was not only ineffective among a large population of working-age healthcare employees–it was associated with a higher risk of infection.

https://greenmedinfo.com/content/bombshell-study-reveals-27-negative-efficacy-2024-2025-influenza-vaccine-among

Posted on: Monday, April 7th 2025 at 11:30 am
Written By: GreenMedInfo Research Group
This article is copyrighted by GreenMedInfo LLC, 2025

2019 Children's Health Defense (CHD) PDF Brochure - Flu Vaccines: What You Need to Know

Download and share this informative brochure on the facts about the flu vaccine.

https://childrenshealthdefense.org/wp-content/uploads/2019-CHD-Flu-Brochure.pdf

2017 CDC Study - Increased Odds of Miscarriage

A 2017 CDC study shows up to a 7.7 times greater risk of spontaneous abortion after influenza vaccine.

https://childrenshealthdefense.org/news/cdc-study-shows-7-7-fold-greater-odds-miscarriage-influenza-vaccine/

References

[28] Miller’s Review of Critical Vaccine Studies. Neil Z. Miller. 2016. P. 64-84

[29] https://www.nvic.org/disease-vaccine/influenza/quick-facts

[30] Vaccine Adverse Events Reporting System – https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf

Vaccine Product Monographs

Product: Flumist Quadrivalent (Astrazeneca)

Product Monograph: https://www.astrazeneca.ca/content/dam/az-ca/downloads/productinformation/flumist-qlaiv-product-monograph-en.pdf (33 pages)

Patient Information sheet: https://www.astrazeneca.ca/content/dam/az-ca/downloads/productinformation/flumist-qlaiv-consumer-information-leaflet-en.pdf

Manufacturer website: https://www.astrazeneca.ca/en/our-medicines.html

Product: Fluzone Quadrivalent (Sanofi)

Product Monograph: https://www.sanofi.com/assets/countries/canada/docs/products/vaccines/fluzone-qiv-en.pdf (31 pages)

Patient Information sheet: https://www.sanofi.com/assets/countries/canada/docs/products/vaccines/fluzone-qiv-pmi-en.pdf

Manufacturer website: https://www.sanofi.com/en